149 related articles for article (PubMed ID: 32438959)
1. Peripheral Artery Disease and Risk of Fibrosis Deterioration in Nonalcoholic Fatty Liver Disease: A Prospective Investigation.
Zhu W; Deng CJ; Xuan LP; Dai HJ; Zhao ZY; Wang TG; Li M; Lu JL; Xu Y; Chen YH; Wang WQ; Bi YF; Xu M
Biomed Environ Sci; 2020 Apr; 33(4):217-226. PubMed ID: 32438959
[TBL] [Abstract][Full Text] [Related]
2. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease.
Chen Y; Xu M; Wang T; Sun J; Sun W; Xu B; Huang X; Xu Y; Lu J; Li X; Wang W; Bi Y; Ning G
Atherosclerosis; 2015 Jul; 241(1):145-50. PubMed ID: 25988358
[TBL] [Abstract][Full Text] [Related]
3. High NAFLD fibrosis score in non-alcoholic fatty liver disease as a predictor of carotid plaque development: a retrospective cohort study based on regular health check-up data in China.
Yu X; Chen C; Guo Y; Tong Y; Zhao Y; Wu L; Sun X; Wu X; Song Z
Ann Med; 2021 Dec; 53(1):1621-1631. PubMed ID: 34498502
[TBL] [Abstract][Full Text] [Related]
4. New Nonalcoholic Fatty Liver Disease and Fibrosis Progression Associate With the Risk of Incident Chronic Kidney Disease.
Zuo G; Xuan L; Xin Z; Xu Y; Lu J; Chen Y; Dai M; Zhang D; Wang W; Li M; Bi Y; Ning G; Xu M
J Clin Endocrinol Metab; 2021 Sep; 106(10):e3957-e3968. PubMed ID: 34125886
[TBL] [Abstract][Full Text] [Related]
5. NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients.
Treeprasertsuk S; Björnsson E; Enders F; Suwanwalaikorn S; Lindor KD
World J Gastroenterol; 2013 Feb; 19(8):1219-29. PubMed ID: 23482703
[TBL] [Abstract][Full Text] [Related]
6. Associations of subclinical atherosclerosis with nonalcoholic fatty liver disease and fibrosis assessed by non-invasive score.
Xin Z; Zhu Y; Wang S; Liu S; Xu M; Wang T; Lu J; Chen Y; Zhao Z; Wang W; Ning G; Bi Y; Xu Y; Li M
Liver Int; 2020 Apr; 40(4):806-814. PubMed ID: 31820847
[TBL] [Abstract][Full Text] [Related]
7. Changes in Insulin Resistance Index and the Risk of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease without Diabetes: Kangbuk Samsung Health Study.
Koo DJ; Lee MY; Jung I; Moon SJ; Kwon H; Park SE; Rhee EJ; Lee WY
Endocrinol Metab (Seoul); 2021 Oct; 36(5):1016-1028. PubMed ID: 34674510
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic Fatty Liver Disease Is Common in IBD Patients However Progression to Hepatic Fibrosis by Noninvasive Markers Is Rare.
Ritaccio G; Stoleru G; Abutaleb A; Cross RK; Shetty K; Sakiani S; Wong U
Dig Dis Sci; 2021 Sep; 66(9):3186-3191. PubMed ID: 32894439
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.
Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N
Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177
[TBL] [Abstract][Full Text] [Related]
10. Association between non-alcoholic fatty liver disease and peripheral artery disease in patients with type 2 diabetes.
Zou Y; Li X; Wang C; Wang J; Wang F; Ma L; You W; Li C
Intern Med J; 2017 Oct; 47(10):1147-1153. PubMed ID: 28696562
[TBL] [Abstract][Full Text] [Related]
11. Fibrosis Risk in Nonalcoholic Fatty Liver Disease Is Related to Chronic Kidney Disease in Older Type 2 Diabetes Patients.
Sun Y; Hong L; Huang Z; Wang L; Xiong Y; Zong S; Zhang R; Liu J; Zang S
J Clin Endocrinol Metab; 2022 Aug; 107(9):e3661-e3669. PubMed ID: 35766414
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study.
Baratta F; Pastori D; Angelico F; Balla A; Paganini AM; Cocomello N; Ferro D; Violi F; Sanyal AJ; Del Ben M
Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2324-2331.e4. PubMed ID: 31887443
[TBL] [Abstract][Full Text] [Related]
13. Lower eGFR is associated with increased probability of liver fibrosis in Chinese diabetic patients.
Wang Y; Yu Y; Wan H; Chen Y; Xia F; Zhang W; Zhang K; Gu X; Zhang Y; Lin Z; Yu Y; Wang N; Lu Y
Diabetes Metab Res Rev; 2020 Jul; 36(5):e3294. PubMed ID: 32017389
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA.
Wijarnpreecha K; Thongprayoon C; Scribani M; Ungprasert P; Cheungpasitporn W
Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):404-410. PubMed ID: 29215435
[TBL] [Abstract][Full Text] [Related]
15. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
[TBL] [Abstract][Full Text] [Related]
16. Ankle systolic pressure index in non-diabetic non-alcoholic fatty liver disease: A case-control study.
Taharboucht S; Guermaz R; Brouri M; Bengherbia L; Chibane A
J Med Vasc; 2023; 48(5-6):154-162. PubMed ID: 38035921
[TBL] [Abstract][Full Text] [Related]
17. Baseline homeostasis model assessment of insulin resistance associated with fibrosis progression in patients with nonalcoholic fatty liver disease without diabetes: A cohort study.
Koo DJ; Lee MY; Jung I; Moon SJ; Kwon H; Park SE; Rhee EJ; Lee WY
PLoS One; 2021; 16(8):e0255535. PubMed ID: 34432804
[TBL] [Abstract][Full Text] [Related]
18. The impact of non-alcoholic fatty liver disease and liver fibrosis on adverse clinical outcomes and mortality in patients with chronic kidney disease: a prospective cohort study using the UK Biobank.
Hydes TJ; Kennedy OJ; Buchanan R; Cuthbertson DJ; Parkes J; Fraser SDS; Roderick P
BMC Med; 2023 May; 21(1):185. PubMed ID: 37198624
[TBL] [Abstract][Full Text] [Related]
19. Non-invasive fibrosis scoring systems can predict future metabolic complications and overall mortality in non-alcoholic fatty liver disease (NAFLD).
Önnerhag K; Hartman H; Nilsson PM; Lindgren S
Scand J Gastroenterol; 2019 Mar; 54(3):328-334. PubMed ID: 30907181
[No Abstract] [Full Text] [Related]
20. The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population.
Jinjuvadia R; Antaki F; Lohia P; Liangpunsakul S
J Clin Gastroenterol; 2017 Feb; 51(2):160-166. PubMed ID: 27580477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
